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ABSTRACT21
Cystic ovarian disease (COD) is one of the main factors responsible for reproductive 22
disorders in cattle. Although the pathogenesis and mechanism of cyst formation are not 23
fully understood, it has been proposed that the IGF system could play an essential role, as 24
it is a key intraovarian regulator. The aim of the present study was to determine whether 25
the altered levels in IGF1 detected in bovines with COD are associated with changes at 26
mRNA level or with differential modulation by IGFBPs. The mRNA levels of the IGF27
components studied were analyzed by real time PCR and in situ hybridization, and IGFBP 28
expression and activity were assayed by immunohistochemistry and ligand blot 29
respectively. Results showed a decreased IGF1 mRNA level due to a lower granulosa cell 30
gene expression in cystic follicles (P < 0.05). Results also showed variations in IGFBP 31
expression in the intraovarian cellular compartment and concentration in follicular fluid,32
and suggest that IGFBP3 is a key regulator of intrafollicular IGF1 in animals with COD.33
34
Keywords: cattle, cystic ovarian disease, insulin-like growth factor, ovaries35
36
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INTRODUCTION37
Ovarian follicular cysts in cattle are characterized by large anovular structures that persist 38
in the ovary for approximately 10 days in the absence of a corpus luteum, with interruption of 39
the normal estrous cycle (Silvia et al., 2002; Vanholder, 2006). The incidence of this disease has 40
been estimated to occur in up to 30% of dairy cows, and the number of cases has increased in 41
recent years (Garverick, 1997; Silvia et al., 2005; Vanholder et al., 2006), probably due to the 42
selection of high-yielding animals. 43
The pathogenesis and mechanism of cyst formation are not fully understood. One of the 44
main difficulties in investigating ovarian cysts in bovines is that there are different factors 45
contributing to cyst formation (Vanholder et al., 2006). However, a hypothalamic 46
unresponsiveness to an estradiol surge appears to be one of the underlying causes of follicular 47
cyst formation in dairy cows (Gümen and Wiltbank, 2002). It is believed that an altered 48
feedback mechanism of estrogens in the hypothalamic-pituitary axis can result in an aberrant 49
GnRH and LH release and cyst formation, where growth factors play an active role.50
The insulin-like growth factor (IGF) system is a key intraovarian regulator and the 51
successful development of a healthy oocyte and appropriate granulosa and theca cell 52
steroidogenesis in the estrous cycle depend on multiple factors, including the proper function of53
this system (Jones and Clemmons, 1995; Spicer, 2004). Disruption of even one component of 54
this system can lead to abnormal follicular development and function, and compromise the 55
reproductive capacity by contributing to the development of follicular cysts (Zulu et al., 2002; 56
Ortega et al., 2008, Rey et al., 2010; Probo et al., 2011).57
The bioavailability of both IGF1 and IGF2 in the follicle is intimately influenced by the 58
relative proportions of IGF-binding proteins (IGFBPs) (Firth and Baxter, 2002, Rey et al., 2010; 59
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Rodríguez et al., 2011) and by the different affinities between the ligands and individual IGFBPs 60
(Jones and Clemmons, 1995; Rey et al., 2010). Six IGFBPs (IGFBP1 to 6) have been described to 61
bind IGF1 and IGF2, prolong their half-lives, and block their action in most situations (Rechler, 62
1993; Firth and Baxter, 2002). On the other hand, evidence exists for proteolytic enzymes that 63
degrade and inactivate IGFBPs during follicular development in mammals. These protease-64
induced decreases in IGFBPs likely cause increased levels of free IGFs, which stimulate 65
steroidogenesis and mitogenesis (Spicer, 2004). Therefore, IGFs are regulated at various levels, 66
with a constantly shifting contribution of endocrine, autocrine and paracrine factors.67
Given the role of the IGF system in the ovarian function, we hypothesized that an 68
imbalance in this system may result in ovarian alterations such as cystic ovarian disease (COD). 69
Therefore, the aim of the present study was to determine whether the altered levels of IGF1 70
previously detected in cattle with COD (Ortega et al., 2008) are associated with changes at 71
mRNA level or with a differential modulation by IGFBPs.72
73
MATERIALS AND METHODS74
Induced cystic follicles and controls 75
All procedures were carried out according to the Guide for the Care and Use of 76
Agricultural Animals in Agricultural Research and Teaching (Federation of Animal Science 77
Societies, 1999) and the protocol was approved by the Ethics and Safety Committee of the 78
Faculty of Veterinary Sciences (Universidad Nacional del Litoral, Argentina). Ten nulliparous 79
Argentinean Holstein heifers (18 to 24 months old; 400 to 450 kg body weight; maintained 80
under standard husbandry conditions) with regular estrous cycles according to prior detection 81
of estrus, rectal palpation and ultrasonography, were used. Their estrous cycles were 82
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synchronized using the Ovsynch protocol as described previously (Ortega et al, 2008; Rodríguez 83
et al., 2011). The day on which estrous behavior was first detected was confirmed by rectal 84
examination and ultrasonography, and designated Day 0 of the cycle (Gümen et al., 2003). 85
Beginning on Day 15 of a synchronized estrous cycle, five heifers received subcutaneous 86
injections of tetracosactrin hexaacetate (1 mg/ml/animal; Synacthen Depot, Novartis, Basel, 87
Switzerland), a synthetic polypeptide with ACTH activity, every 12 h for 7 days (Ortega et al., 88
2008). Five control animals received saline (1 ml) (Dobson et al., 2000; Ortega et al., 2008). 89
Ultrasonographic ovarian examinations were performed in all animals, as previously described,90
using a real-time, B-mode scanner equipped with a 7.5 MHz, linear-array, transrectal transducer 91
(Aloka, SSD 500; Wallingford, CT, USA) (Sirois and Fortune, 1988; Rodríguez et al., 2011). Daily 92
ovarian ultrasonography was performed throughout one complete estrous cycle (21 days in the 93
control group) and from Day 14 (Day 0 = day of estrus) until Day 48 (treated group). Cysts 94
detected by ultrasonography were defined as any follicular structure equal to or greater than 20 95
mm in diameter that was present for 10 days without forming a corpus luteum (CL) (Dobson et 96
al., 2000; Silvia et al., 2002). The first day of cyst formation was identified retrospectively, 10 97
days before the daily detection of a follicle equal to or greater than 20 mm in diameter. The 98
ovaries were removed 10 days later, for the identification of follicular cysts, by flank 99
laparatomy. Control heifers were ovariectomized, to obtain normal growing follicles 100
(approximately Day 18), when the dominant follicle reached a diameter greater than 10 mm. 101
During dissection of the ovaries, the follicular diameter was measured using callipers and 102
follicular fluid from each follicle was aspirated and stored separately at -20°C. Tertiary (antral) 103
follicles dissected from normally cycling ovaries were classified as small (< 5 mm), medium-sized 104
(5–10 mm) or large (> 10 mm) (Parrott and Skinner, 1998). Blood samples were obtained 105
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immediately before ovarian excision and centrifuged at 1000 x g for 30 min. The serum 106
collected was stored at -20 °C until hormonal analysis (parallel studies Ortega et al., 2008; Rey et 107
al., 2010). Luteinization of cystic follicles was discarded by means of hormonal analysis. 108
Follicular fluid was aspirated from both the preovulatory follicles of control animals and induced 109
cystic follicles and then frozen until analysis. The ovaries were fixed in 4 % neutral buffered 110
formalin.111
112
Spontaneous cystic ovaries113
Ovaries with spontaneous cystic follicles were obtained from dairy cows by flank 114
laparotomy. Eight pluriparous (mean 3.1 ± 1.5 lactations, range 2-7), high-yielding (mean 25.12 115
± 6.23 kg of milk per day at diagnosis) Argentinean Holstein cows affected by COD were 116
previously monitored by ultrasonography, and when a follicle ≥20 mm in diameter persisting for 117
10 days in the absence of a functional CL was detected, animals were ovariectomized. Cystic 118
fluids from animals with COD were aspirated using a probe of the real-time, B-mode scanner 119
equipped with a 7.5 MHz, linear-array, transrectal transducer (Aloka, SSD 500; Wallingford, CT, 120
USA) before ovarian excision. After excision, samples were collected, refrigerated on ice and 121
immediately transported to the laboratory. Follicular cysts were evaluated grossly, 122
microscopically and by hormone analysis. Tissue fractions of ovaries from cystic follicles were 123
immediately frozen at -80 °C until use in gene expression assays. Additional sections of ovarian 124
tissue were fixed in 4 % neutral buffered formalin.125
126
Tissue preparation 127
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For light microscopy, the fixed tissues were dehydrated and embedded in paraffin wax. 128
Sections (4 µm in thickness) were mounted on slides previously treated with 3-129
aminopropyltriethoxysilane (Sigma-Aldrich, St. Louis, MO, USA) and assigned for staining with 130
hematoxylin and eosin for preliminary observations of all ovarian structures (Salvetti et al., 131
2004) or for use in immunohistochemistry (IHC) or in situ hybridization (ISH). Follicles were 132
classified into primary, secondary, tertiary and cystic follicles (Silvia et al., 2002).  133
134
RNA extraction135
Total RNA was isolated from the follicular wall of different sized tertiary control follicles 136
and cysts, after treatment with Trizol LS reagent (Invitrogen, Life technology, CA, USA),137
according to the manufacturer’s instructions but with slight modifications (Rey et al., 2010; 138
Rodríguez et al., 2011). 139
140
Reverse transcription141
To avoid putative genomic DNA contamination, RNA samples were treated with DNAse 142
(Invitrogen) according to the manufacturer’s instructions. First strand cDNA was synthesized143
using a master mix (Moloney Murine Leukemia Virus (MMLV) buffer, dithiothreitol (DTT), 144
RNAout, MMLV reverse transcriptase, deoxyribonucleotide triphosphate (dNTP) and random 145
primers (Invitrogen)). The reverse transcription conditions were as described previously146
(Rodríguez et al., 2011).147
148
Real Time PCR149
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An optimized real time PCR protocol was used to analyze the mRNA expression of IGF1, 150
IGFBP1, IGFBP4, IGFBP5 and IGFBP6 using SYBR Green I (Invitrogen) technology in LightCycler151
(Pfaffl et al., 2001). The IGFBP2 and IGFBP3 mRNA had been analyzed in a previous work 152
(Rodríguez et al., 2011).153
Transcript levels were measured by relative quantitative real time PCR using a StepOne 154
Real Time PCR System (Applied Biosystems, Life technology, CA, USA). An optimized protocol 155
was used: initial denaturation at 95 °C for 10 min, 36 cycles of denaturation at 95 °C for 15 s and 156
annealing 62 °C (IGF1), 58 °C (IGFBP1), 60 °C (IGFBP4, IGFBP6), 63 °C (IGFBP5), and 52 °C 157
glyceraldehyde 3-phosphate dehydrogenase (GAPDH) for 20 s, extension at 72 °C for 30 s and 158
fluorescence reading at 74 °C. All measurements for each sample were performed in duplicate. 159
The efficiency of PCRs and relative quantities were determined from a six-point standard curve. 160
Standard curves were constructed from a dilution series of pooled cDNAs (including six dilutions 161
from 1/5 to 1/160), and PCR efficiency was calculated using the StepOne software v2.2. In 162
standard curves, R2: 0.99, except in the case of GAPDH, where R2: 0.98. About 15 ng cDNA was 163
used for all primers, except for IGFBP-1, where 90 ng was used for each real time PCR reaction, 164
and was previously quantified by the Qubit method (Invitrogen). For amplification, 4 µl of cDNA 165
was combined with a PerfeCta SYBR Green SuperMix, ROX (Quanta Biosciences, Inc., MD, USA) 166
in a final volume of 20 µl. The primer sequences used are described in Table 1. The GAPDH gene 167
sequence was included as the housekeeping gene.168
The mRNA expression levels of genes were recorded as cycle threshold (Ct) values that 169
corresponded to the number of cycles at which the fluorescence signal can be detected above a 170
threshold value. The Ct was calculated manually using StepOne v2.2 (Applied Biosystems). 171
Negative DNA template controls were included in all the assays, and yielded no consistent 172
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amplification. Product purity was confirmed by dissociation curves, and random samples were 173
subjected to agarose gel electrophoresis. Fold change was determined using the 2-ΔΔCt method 174
(Livak et al., 2001). 175
176
Nucleotide sequencing177
The specificities of the PCR products were checked by direct sequencing to ensure 178
amplification of the correct sequences using the Macrogen Sequencing Service (Macrogen, 179
Korea). The resulting sequences were verified using the MegAlign Tool in the LASERGENE 180
software (DNAStar, WI, USA).181
182
In situ hybridization183
All reagents and materials were RNase-free. Sections were prepared as described above, 184
but using RNase-free conditions. Single-stranded oligonucleotide probes of 45 bases, end-185
labeled with biotin (Invitrogen) were used and, together with those detected previously 186
(Rodríguez et al., 2011), we assayed the main IGFBPs described in bovines. Probe sequences are 187
described in Table 2.188
Probes were diluted to a final concentration of 200 ng/ml in a hybridization solution189
(Sigma). The sections were dewaxed, hydrated and endogenous peroxidase activity was 190
inhibited with 1 % H2O2 in methanol. After washing with Tris-buffered saline (TBS) and sterile 191
water, sections were subjected to microwave pre-treatment in citrate buffer (pH 6.0). After 192
washing with TBS, the corresponding probe was added to each slide and the sections were 193
incubated in a humid chamber overnight at 45 °C (Llewellyn et al., 2007). Following incubation, 194
the slides were washed with TBS and a pre-warmed astringent solution (one wash of saline-195
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sodium citrate (SSC) 2X-50 % formamide-0.05 % Tween for 5 min, followed by two washes of 196
SSC 2X for 10 min, one wash of SSC 1X for 10 min and one wash of SSC 0.1X for 15 min, all at 197
45 °C; finally one wash with SSC 0.1X for 5 min at room temperature). The slides were then 198
rinsed with distilled water and TBS and incubated with extravidin-peroxidase (1:200, Sigma) for 199
30 min at 25°C. A positive reaction was visualized using 3,3’-diaminobenzidine (DAB, Liquid DAB-200
Plus Substrate Kit, Zymed, CA, USA) as the chromogen. Finally, the slides were washed in 201
distilled water and then counterstained with Mayer’s hematoxylin, dehydrated and mounted. 202
To verify specificity, adjacent negative control sections were subjected to the same procedure, 203
replacing the probe with hybridization solution or incubating with a sense probe. The same 204
hybridization temperature, washing and detection conditions were used for the probes used.205
206
Immunohistochemistry207
Protein expression of IGFBP1, IGFBP4, IGFBP5 and IGFBP6 was detected using polyclonal 208
antibodies (conditions in Table 3; Novozymes GroPep Ltd, Australia). The extravidin biotin 209
immunoperoxidase method was carried out as described previously (Ortega et al., 2009; Salvetti 210
et al., 2009). For antigen visualization, DAB was used as the chromogen. Negative control 211
sections in which the primary antibody was replaced by a non-immune rabbit serum were 212
included (Ortega et al., 2009). Some sections were incubated with DAB alone to exclude the 213
possibility that endogenous peroxidase activity had been unsuccessfully blocked. 214
215
Western blotting216
To test the specificity of the primary antibodies used, bovine tertiary follicles were 217
homogenized in a radio-immunoprecipitation assay lysis buffer with a protease inhibitor cocktail 218
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(Complete Mini Protease Inhibitor Cocktail Tablets, Roche, Mannheim, Germany), as described 219
previously (Rodríguez et al., 2011). To this end, 40 µg of protein, along with pre-stained 220
molecular weight markers (GE Healthcare Buckinghamshire, UK) were separated in SDS-PAGE 221
containing 15 % (w/v) acrylamide-polyacrylamide, according to a procedure previously 222
described (Ortega et al., 2009). After blotting on nitrocellulose membranes (Hybond ECL 223
Nitrocellulose Membrane, GE Healthcare), the membranes were blocked with TBS containing 224
0.05 % v/v Tween20 (TBST, Sigma-Aldrich Corp.) and 5 % w/v non-fat milk, and then incubated 225
overnight at 4ºC with specific primary antibodies. Bound antibody was detected using anti-226
rabbit IgG peroxidase antibody (Amersham, Buckinghamshire, UK; 1:500) and ECL plus western 227
blotting detection reagents (GE Healthcare).228
229
Western ligand blot230
Samples of follicular fluid were separated electrophoretically under non-reducing 231
conditions and transferred onto a nitrocellulose membrane as described previously (Rey et al., 232
2010). Membranes were blocked with 5 % w/v bovine serum albumin (Sigma-Aldrich) in TBS and 233
then incubated overnight at 4°C with 750 ng/ml of biotinylated IGF1 (Novozymes GroPep). 234
Membranes were washed with TBST, and incubated with a 1:5000 dilution of extravidin-235
peroxidase (Sigma-Aldrich) in blocking solution. Before washes with TBST, signal was detected236
by chemiluminescence using the ECL-Plus system (GE Healthcare) on hyperfilm-ECL film (GE 237
Healthcare). Individual binding proteins were identified on the basis of their molecular weights, 238
as reported previously (Jones and Clemmons, 1995; Nicholas et al., 2002). The molecular weight 239
reported for IGFBP3 corresponds to a double band of 40 and 44 kDa. IGFBP2 was detected at 34 240
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kDa, IGFBP4 has been reported to have a glycosylated and a non-glycosylated form, with 241
molecular weights of 29 and 24 kDa, respectively, and IGFBP5 was observed at 31 kDa.242
243
Image analysis244
Images were analyzed using the Image Pro-Plus 3.0.1 system (Media Cybernetics, Silver 245
Spring, MA, USA). Images were digitized using a color video camera (Motic 2,000, Motic China 246
Group, China) mounted on top of a conventional light microscope (Olympus BH-2, Olympus Co., 247
Japan) using an objective magnification of × 40, as described and validated previously (Ortega et 248
al., 2009, 2010; Rodríguez et al., 2011). To obtain quantitative data for IHC and ISH labeling of 249
IGFBPs in the follicular wall, at least three sections were evaluated for each specimen and 250
antibody or oligonucleotide. The average density (% of positive area) of the IGFBPs antibody or 251
oligonucleotide reaction was calculated from at least 20 images of each area (granulosa and 252
theca cells) in each section as a percentage of the total area evaluated through color 253
segmentation analysis, which extracts objects by locating all objects of a specific color (brown 254
stain) (Ortega et al., 2009). 255
For the western ligand blot, the exposed films were scanned at 1200 dpi (scanner HP 256
Officejet J5, 780). The level of each IGFBP was analyzed by densitometry to obtain an integrated 257
optical density (IOD) value, which was compared between follicular fluid samples from healthy 258
and cystic ovaries (Rey et al., 2010).259
260
Statistical analysis261
A statistical software package (SPSS 11.0 for Windows, SPSS Inc., Chicago, Illinois, USA) 262
was used to analyze the data. Tests of homogeneity of variance among groups were conducted 263
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using Levene’s test. The statistical significance of differences between groups of data was 264
assessed by one-way ANOVA, followed by Duncan’s multiple range tests as a multiple 265
comparison test. A value of P < 0.05 was considered significant. The results are expressed as 266
mean ± SD.267
268
RESULTS269
IGF1 and IGFBPs gene expression270
The identity of the PCR products was confirmed by sequencing (100% homology with 271
bovine sequences). No differences were detected in GAPDH gene expression between the 272
different groups evaluated (P > 0.05).273
Levels of mRNA of IGFBP1, IGFBP4, IGFBP5 and IGFBP6 in the complete follicular wall of 274
control tertiary follicles of different sizes and cystic follicles were similar (P > 0.05) (Figure 1).275
Moreover, no differences were detected in the levels of IGF1 of tertiary follicles and cystic 276
structures (P > 0.05) (Figure 2A). However, when mRNA expression was analyzed in different 277
follicular cells by ISH, IGFBP5 was detected mainly in granulosa cells, where the expression 278
determined in cystic structures was lower than that in growing follicles (Figure 3B and 4). 279
Growing follicles from both control and cystic ovaries showed a decreasing expression from 280
primary to tertiary follicles. IGFBP5 mRNA was detected in theca cells of cystic follicles, but a 281
very low presence or complete absence was detected in theca cells of tertiary follicles. 282
IGFBP4 was detected in granulosa and theca cells, and no differences were observed in 283
the structures analyzed (P > 0.05) (Figure 3). Similarly to that observed in mRNA expression of 284
IGFBP5, in granulosa cells, IGFBP4 mRNA levels decreased as follicles grew, and the lowest levels 285
were detected in cystic structures (P < 0.05).286
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IGF1 mRNA was detected only in granulosa cells, with similar levels between structures of 287
the same group (control, spontaneous COD and experimentally induced COD). However, 288
reduced levels were detected in growing follicles and cysts from ovaries with induced COD 289
compared with control and spontaneous COD (P < 0.05).290
Structures analyzed in follicles from ovaries with spontaneous COD consistently showed 291
higher positive labeling than follicles from ovaries with experimentally induced COD, and the 292
expression pattern was similar in each structure analyzed (Figure 2B, 3).293
294
Protein expression of IGFPs295
Expressions of IGFBP1, IGFBP4, IGFBP5 and IGFBP6 were evaluated in follicles of different 296
developmental stages. Insulin-like growth factor binding protein 4, IGFBP5 and IGFBP6 were 297
detected both in granulosa and theca cells, with greater levels in granulosa cells (Figure 6), 298
whereas IGFBP1 was not observed in either cell type. 299
Both IGFBP4 and IGFBP5 showed the lowest expression levels in granulosa cells of cystic 300
structures, and the highest expression in primary follicles of control ovaries as well as in ovaries 301
with COD (P < 0.05) (Figure 7). Theca cells of experimentally induced cystic follicles showed 302
lower expression levels of IGFBP4 than control tertiary follicles (P < 0.05) and expression levels 303
similar to those of spontaneous cystic follicles (P > 0.05). Expression levels of IGFBP5 were 304
similar in the control and induced structures analyzed (P > 0.05), and different from those in 305
spontaneous structures (P < 0.05).306
In contrast, IGFBP6 expression in granulosa cells increased expression from primary to 307
tertiary follicles, with larger levels in cystic follicles of experimentally induced COD (P < 0.05) 308
(Figure 7). Once more, the levels were higher in the structures from spontaneous COD and 309
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increased from primary to secondary follicles, and then remained constant through tertiary and 310
cystic follicles. IGFBP6 was not detected in theca cells.311
312
Follicular fluid content of IGFBPs313
The content of IGFBPs in follicular fluid from different sized follicles was identified based 314
on their molecular weight (Nicholas et al., 2002). The western ligand blot allowed for the 315
identification of IGFBP2 (34 kDa), a doublet corresponding to IGFBP3 (40-44kDa), IGFBP4 in its316
glycosylated (29 kDa) and non-glycosylated forms (24 kDa), and IGFBP5 (31 kDa). Their identities317
were confirmed by western blot. The patterns for IGFBP2 and IGFBP3 have been shown in a 318
previous work (Rodríguez et al., 2011), whereas those for IGFBP4 and IGFBP5 are shown in 319
Figure 8.320
IGFBP2 and IGFBP3 were expressed at higher levels in the follicular fluid of the structures 321
analyzed than the other IGFBPs detected. However, while IGFBP2 levels remained practically 322
constant in tertiary follicles and cysts (P > 0.05), IGFBP3 levels were higher in cysts than in small 323
tertiary follicles (P < 0.05). In contrast, the glycosylated form of IGFBP4 and IGFBP5 showed324
higher levels in small tertiary follicles than in cysts and tertiary follicles greater in size (P < 0.05).325
No differences in the non-glycosylated form of IGFBP4 were detected in the follicles analyzed 326
(Figure 8).327
328
DISCUSSION329
The study of the etiopathogenesis of COD in dairy cows has several limitations. The main 330
difficulties are the fact that bovine COD is a multifactorial disease and there are few 331
opportunities to follow clinical cases without treatment because farmers need their cows to 332
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receive treatment as soon as possible (Ribadu, 2000; Probo et al., 2011). For this last reason, 333
many studies have been conducted with slaughterhouse material, which lacks the reproductive 334
history and information of cyst persistence. In the present study, we were able to follow the335
reproductive behavior by ultrasonography and rectal palpation of the dairy cows identified as 336
having COD, and thus to promptly detect persistent follicles and development of cysts. 337
Moreover, since follicular cysts were recovered from experimental animals at known times after 338
cyst emergence, analysis of their structure and function was more accurate (Ortega et al., 2008). 339
In the present study, we determined that IGFBP4 and IGFBP5 mRNA levels in granulosa 340
cells decreased from primary to tertiary follicles in the control group, similarly to that observed 341
in sheep (Hastie et al., 2004; Hastie and Haresign, 2006). Interestingly, IGFBP4 mRNA was 342
detected mainly in granulosa cells, but expressed in lower levels in theca cells, contrarily to that343
observed by other authors (Armstrong et al., 1998; Roberts and Etcherntkamp, 2003).344
Moreover, the reduced levels of IGFBP4 and IGFBP5 detected in granulosa cells of cystic ovaries345
were more evident in the experimental model than in spontaneous cysts, probably due to the 346
differences in the environmental conditions and the time of persistence of the cysts, which347
could influence the gene expression of these IGFBPs. Consistently, IGFBP5 protein expression 348
showed a similar pattern. On the other hand, similar protein levels of IGFBP4 were observed in 349
the structures from ovaries from spontaneous and induced COD. Differences in mRNA levels 350
related to protein expression could be due to the hormonal milieu that participates in the 351
control of the IGFBP system and proteins associated such as IGFBP proteases (Spicer, 2004; Aad 352
et al., 2006; Sudo et al., 2007). Moreover, it is worth mentioning that levels detected by IHC353
correspond to the glycosylated form of IGFBP4, as demonstrated by western blot. 354
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In support of the control exerted by steroid hormones on IGFBP production, Spicer and 355
Chamberlain (2000) observed that estradiol inhibited IGFBP4 production in bovine granulosa 356
cells in vitro, but did not determine whether this inhibition was due to a change in the357
proteolysis of IGFBP4. IGF1, FSH, and/or estradiol induce IGFBP4 proteolysis in cultured human 358
granulosa cells (Iwashita et al., 1998). In addition, the reduced levels of IGFBP4 and IGFBP5 359
determined in spontaneous and experimentally induced cystic follicles as compared with those 360
in primary follicles from both control and COD ovaries are probably associated with the lower 361
mRNA levels detected, although control by IGFBP proteases cannot be ruled out. It has been362
suggested that IGFBP4 production, via changes in intrafollicular mRNA expression, is correlated 363
with LH regulation and IGFBP4 degradation (Mazerbourg et al., 2001; Hastie and Haresing, 364
2010). Moreover, both FSH and LH inhibit the expression of IGFBP5 mRNA in ovine follicles, 365
determining a decrease in the levels of IGFBP5 mRNA (Besnard et al., 1996a; Hastie and 366
Haresign, 2006a) and protein (Monget et al., 1993; Spicer and Chamberlain, 2002) in follicles as 367
they increase in diameter (Hastie and Haresing, 2010). 368
Since there is limited information about the patterns of IGFBP1 and IGFBP6 mRNA and 369
protein expression in the ovary of ruminants, little is known about the elements that regulate370
these binding proteins. In the present study, we found no changes in IGFBP1 and IGFBP6 mRNA 371
levels in the follicular wall of the tertiary and cystic structures analyzed, and detected no protein 372
expression in any of the follicles analyzed. Because lower levels of IGFBP1 and IGFBP6 mRNA 373
detected, not expression of those binding proteins mRNA were analyzed by situ hybridization. It 374
has been reported that IGFBP1 concentrations in serum and follicular fluid are decreased in 375
women with polycystic ovary syndrome (Thierry van Dessel et al. 1999). In bovines, IGFBP1 is376
detected in small quantities in the follicular fluid, probably because it is either poorly expressed 377
Page 18 of 42
Ac
ce
pte
d M
an
us
cri
pt
or not synthesized within the follicle compartment, entering the basal membrane as a result of 378
changes (Nicholas et al. 2002). Probably, these changes could explain why we detected mRNA 379
but not protein. This lack of detection of protein may also be due to the methodology used 380
(IHC). This may also be true because we failed to detect both IGFBP1 and IGFBP6 in follicular 381
fluid by ligand blot (Nicholas et al., 2002), but found IGFBP6 in granulosa cells.382
Although IGFBPs were synthesized intrafollicularly (Armstrong et al., 1998; Voge et al., 383
2004; Rodríguez et al., 2011), we analyzed the levels of IGFBPs in follicular fluid, where IGF 384
availability is effectively regulated. Changes in IGFBP concentrations in bovine follicular fluid 385
have been documented during follicle growth and development in cattle (de la Sota et al., 1996; 386
Stewart et al., 1996), sheep (Perks and Wathes, 1996), and pigs (Yuan et al., 1996). Typically,387
dominance is associated with decreased follicular fluid concentrations of the binding proteins388
with lower molecular weight, i.e. IGFBP4 and IGFBP5 (Austin et al., 2001), in agreement with our 389
present results, which showed lower protein concentrations in tertiary follicles increasing in 390
size. The changes in the IGFBP content of follicular fluid could be due to the regulation of IGFBP 391
production, changes in the activity of specific IGFBP proteases, or changes in the selective 392
uptake of IGFBPs from the circulation during follicle growth (Armstrong et al., 1998). In fact, we 393
detected lower gene expression of IGFBP4 and IGFBP5, which was reflected in lower protein 394
synthesis, while follicles were growing from primary to tertiary and cystic follicles. However, no 395
changes were detected in mRNA or protein expression levels of control tertiary follicles when 396
compared with spontaneous cystic follicles. In follicular fluid, a decreasing concentration of 397
IGFBP5 was detected through tertiary follicles growing in size until cystic structures. Similar 398
results were obtained with the 29-kDa glycosylated form of IGFBP4, although no changes were 399
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detected with the 24-kDa non-glycosylated form. The lower levels detected could result from an 400
increasing activity or concentration of IGFBP protease. 401
Previously, we detected similar protein expression of IGFBP2 and IGFBP3 in tertiary 402
control and cystic follicles (Rodríguez et al., 2011). However, the concentration of IGFBP3 in 403
follicular fluid increased as the control tertiary follicles increased in size, with the highest 404
concentration found in cystic structures. Therefore, the differences detected in IGFBP3 content 405
in follicular fluid support the hypothesis of an extrafollicular origin (Echternkamp et al., 1994; 406
Santiago et al., 2005; Rey et al., 2010), probably responsible for the bioavailability of IGF1.407
In previous studies, we detected similar serum IGF1 concentrations in controls and 408
animals with spontaneous or induced cystic ovarian disease (Ortega et al., 2008). Part of the 409
lack of a direct effect on ovarian activity depends on how much of the circulating IGF1 410
concentration is truly reflected in the ovaries. IGF1 concentration in follicular fluid has been 411
found to be lower (Echternkamp et al., 1990; Spicer et al., 1991), equal to (Spicer et al., 1992), 412
or greater (Spicer et al., 1992; Ortega et al., 2008) than peripheral IGF1 concentration, and 413
although they are correlated, in some circumstances, such as short-term fasting, liver-derived 414
IGF1 can be decreased significantly without affecting intrafollicular IGF1 concentration (Spicer et 415
al., 1992; Velazquez et al., 2008). Furthermore, it has been suggested that IGF1 is involved not 416
only in the pathogenesis but also in the maintenance of COD in cattle (Zulu et al., 2002; Probo et 417
al., 2011). In this pathological condition, while IGF1 concentrations are known to be lower 418
during ovarian cyst formation (Beam and Butler 1997, 1998; Zulu et al. 2002), intrafollicular IGF1419
can be even lower than serum concentrations (Ortega et al., 2008). Considering the alterations 420
in the expression of IGFBP2 and IGFBP3 reported previously (Rodríguez et al., 2011) and the 421
results of the present study, we suggest that the decreased IGF1 levels could result from422
Page 20 of 42
Ac
ce
pte
d M
an
us
cri
pt
alterations in the diffusion rate between the blood and the follicular fluid. These alterations423
could be due to differences in the interaction with IGFBPs related to gene and protein 424
expression and/or to induced changes attributable to a decreased IGF1 mRNA in ovaries with 425
induced COD, causing an imbalance in the IGF system that could modify the circulating levels of 426
the free fraction of IGF (Rechler and Clemmons, 1998; Hastie and Haresing, 2006; Thomas et al., 427
2007). 428
429
CONCLUSION430
The results of the present study support that the IGF system has a clear influence in cows 431
with COD. We suggest that IGF1 is influenced by the action of IGFBPs, mainly by IGFBP3 and by 432
the decreased level of IGF1 mRNA during a COD condition.433
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FIGURE LEGENDS
Figure 1: Expression of IGFBP1, IGFBP4, IGFBP5 and IGFBP6 mRNA in small (S), medium 
(M) and large (L) tertiary follicles and cysts (C). No differences were detected in the
quantification of the PCR products of IGFBP1 (A), IGFBP4 (B), IGFBP5 (C) and IGFBP6 (D). 
Values represent the mean ± SD.
Figure 2: Expression of IGF1 mRNA levels in follicular structures. (A) Quantification of IGF1 
mRNA in ovarian follicular wall of small (S), medium (M) and large (L) tertiary follicles and 
cysts (C) by real time PCR. No differences were detected in the PCR products of IGF1
mRNA. (B) Analysis of cell population by in situ hybridization showed decreased 
expression of IGF1 in experimentally induced cysts (black bars) related to control follicles 
(open bars) without differences in spontaneous cystic ovaries (hatched bars). Values 
represent the mean ± SD. Bars with different superscript letters denote significant 
differences (P < 0.05). 
Figure 3: Expression of IGFBP4 and IGFBP5 mRNA levels by in situ hybridization. 
Quantification of IGFBP4 mRNA in granulosa and theca interna cells (A) and quantification 
of IGFBP5 mRNA in granulosa cells (B) in developing follicles of control ovaries (open bars), 
experimentally induced cystic ovaries (black bars) and spontaneous cystic ovaries (hatched 
bars). Values represent the mean ± SD. Bars with different superscript letters denote 
significant differences (P < 0.05). C: control, I: induced cystic ovaries, S: spontaneous cystic 
ovaries.
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Figure 4: Representative images of IGFBP4 (A-C) and IGFBP5 (D-F) mRNA localization by in
situ hybridization in bovine follicles. The immunoreactivity was intense in granulosa cells 
of tertiary control follicles (A, D) and weaker in cystic follicles (B, E). No staining was 
observed when the sense probe was pre-incubated with the antisense probe as negative 
control (C, F). In the right column, the immunopositive areas of A and D were segmented 
by digital image analysis, showing in black the differential cytoplasmic immunostaining 
pattern. Bars = 25 μm
Figure 5: Representative images of IGF1 mRNA localization by in situ hybridization in 
bovine follicles. The immunoreactivity was intense in granulosa cells of secondary (A) and 
tertiary (B) control follicles and weaker in cystic follicles (C). No staining was observed 
when the sense probe was pre-incubated with the antisense probe as negative control
(D). Bars = 25 μm.
Figure 6: Representative images of IGFBP4 (A-C), IGFBP5 (D-F) and IGFBP6 (G-I) protein 
localization by immunohistochemistry in bovine follicles. The immunoreactivity was 
intense in granulosa cells and reduced in theca cells in the follicular structures analyzed. 
Images represent tertiary control follicles (A, D, G) and cystic follicles (B, E, H). No staining 
was observed when the primary antibody was replaced with normal rabbit serum 
(negative control C, F, I). Verification of antibody specificity by western blot analysis of an 
ovarian homogenate demonstrating the specificity of the antibody is shown on the left. In 
the right column, the immunopositive areas of A, D and G were segmented by digital 
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image analysis, showing in black the differential cytoplasmic immunostaining pattern.
Bars = 25 μm
Figure 7: Immunohistochemical staining of IGFBP4 (A), IGFBP5 (B) and IGFBP6 (C), showing 
the percentage of immunopositive areas in granulosa and theca interna cells evaluated in 
primary, secondary, and tertiary follicles of control ovaries (open bars), experimentally 
induced cystic ovaries (black bars) and spontaneous cystic ovaries (hatched bars). Values 
represent the mean ± SD. Bars with different superscript letters denote significant 
differences (P < 0.05) in separate granulosa and theca cell compartments. The theca 
interna was not labeled for IGFBP6. 
Figure 8: Detection of IGFBPs in follicular fluid by western ligand blot of healthy small (S), 
medium (M) and large (L) tertiary follicles compared with cystic follicles (C). A: 
Quantification of IGFBP subtypes as determined by molecular weight: IGFBP4 non-
glycosylated form of 24 kDa (open bars), IGFBP4 glycosylated form of 29 kDa (squared 
bars), IGFBP5 (horizontally hatched bars) of 31 kDa, IGFBP2 (black bars) of 34 kDa and 
IGFBP3 (diagonally hatched bars). Values represent the mean ± SD. Bars with different 
superscript letters denote significant differences (P < 0.05) between different follicle 
types. B: Representative western ligand blot showing the IGFBPs that bind to IGF1.
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Table 1: Forward and reverse primer sequences (5’→3’)
Primer Sequence (5’→3’) Length, 
bp
Reference
IGF1 For1 TCG CAT CTC TTC TAT CTG GCC CTG T
Rev2 GCA GTA CAT CTC CAG CCT CCT CAG A
240 Pfaffl et al. 
(2002)
IGFBP1 For TCA AGA AGT GGA AGG AGC CCT
Rev AAT CCA TTC TTG TTG CAG TTT
123 Pfaffl et al. 
(2002)
IGFBP4 For GCC CTG TGG GGT GTA CAC
Rev TGC AGC TCA CTC TGG CAG
342 Plath- Gabler 
et al. (2001)
IGFBP5 For TGC GAG CTG GTC AAG GAG
Rev TCC TCT GCC ATC TCG GAG
257 Plath- Gabler 
et al. (2001)
IGFBP6 For AGA AAG AGG ATT TGC CTT TGC
Rev TCC GGT AGA AGC CCC TAT G
324 Plath- Gabler 
et al. (2001)
GAPDH For CAC CCT CAA GAT TGT CAG CA
Rev GGT CAT AAG TCC CTC CAC GA
103 Shibaya et al. 
(2007)
1 Forward (For)
2 Reverse (Rev)
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Table 2: Probe sequences (5’→3’)
Probe Sequence (5’→3’) Reference
IGF1 TCACATCCTCCTCGCATCTCTTCTATCTGGCCCTGTGCTTGCTCG (Llewellyn et al., 
2008)
IGFBP4 AAGACGGGAGTGAAGCTTCCGGGGGGCCTGGAGCCGAAGGG
GGAG
901–945 of bovine 
IGFBP4 mRNA 
(Moser et al. 1992)
IGFBP5 CTACTCGCCCAAGATCTTCCGGCCCAAGCACACCCGCATCTCCG
A
291–335 of bovine 
IGFBP5 gene
(Moser et al. 1992)
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Table 3: Antibodies, suppliers and dilutions used
Antibodies Type Supplier Dilution
Primary antibodies
IGFBP1 Polyclonal Novozymes GroPep Ltd, Australia --
IGFBP4 Polyclonal Novozymes GroPep Ltd, Australia 1:100
IGFBP5 Polyclonal Novozymes GroPep Ltd, Australia 1:75
IGFBP6 Polyclonal Novozymes GroPep Ltd, Australia 1:200
Secondary antibody
Anti-rabbit IgG Polyclonal Zymed, CA, USA 1:200
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Figure 2
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Figure 3
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Figure 7
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Figure 8
